Raphael Rosenhek, M.D.
Associate Professor
Director Clinic for Valvular Heart Disease
Department of Cardiology, Medical University Vienna
Währinger Gürtel 18-20, A-1090 Vienna, Austria
Phone: +43-1-40400-4614; Fax: +43-1-40400-4216
Email: raphael.rosenhek@meduniwien.ac.at
Areas of Specialization
Valvular Heart Disease, Echocardiography
Education
MD Faculty of Medicine, University of Vienna 1998
Associate Professor, Cardiology, Medical University of Vienna 2005
Academic Position
Director, Clinic for Valvular Heart Disease, Medical University of Vienna since October
2007
Professional Affiliation
Member of the Nucleus of the Working Group on Valvular Heart Disease
of the European Society of Cardiology (ESC), 2002Treasurer of the Nucleus of the Working Group on Valvular Heart Disease of the
European Society of Cardiology (ESC), 2006-2008
Scretary of the Nucleus of the Working Group on Valvular Heart Disease of the
European Society of Cardiology (ESC), 2008Editorial Functions
Heart: associate editor since july 2006
Medscape Cardiology, contributing editor (since 1999)
Member of the Faculty of 1000 Medicine for Cardiovascular Disorders
(Section Valvular Heart Disease) 2004-2008
Cardiology: Editorial Board Member since march 2008
Archives of Cardiovascular Diseases: Member of the scientific committee
(formerly “Archives des Maladies du Coeur et des vaisseaux”) since January
2008
Awards
1
Advancement Grant of the Medical Faculty of the University of Vienna
1997
for the research work “Differential expression of tissue-type plasminogen
activator in the aorta and the pulmonary artery”.
2
Cournand and Comroe Young Investigator Prize in Cardiopulmonary and
Critical Care finalist at the 71st Scientific Sessions of the American Heart
Association, 1998, Dallas, Texas, USA for the work “Increased fibrinolytic gene
expression in pulmonary artery”.
2
Travel grant of the Austrian Society of Cardiology 1999 for the work “The
natural history of asymptomatic severe aortic stenosis” presented at the European
Society of Cardiology congress 1999, Barcelona, Spain.
3
Poster award (second prize) Austrian Society of Cardioloy congress 2000 for
the work “Elective aortic valve replacement in asymptomatic patients with
severe aortic stenosis? Selection of high risk patients by echocardiography”,
Gmunden. Austria
4
Travel grant of the Austrian Society of Cardiology 2000, for the work “Can
Echocardiography Identify Patients With Severe but Asymptomatic Aortic
Stenosis Who May Benefit From Elective Surgery” presented at the European
Society of Cardiology congress 2000, Amsterdam, Netherlands.
5
Austrian Cardiology award (second prize), Austrian Society of Cardioloy
2001 for the work “Predictors of outcome in severe, asymptomatic aortic
stenosis” Linz, Austria.
6
Poster award (third prize) Austrian Society of Cardioloy congress 2003,
Vienna, Austria.
7
Travel grant of the Austrian Society of Cardioloy 2003, for the work “Statins
but not ACE-inhibitors reduce aortic stenosis progression”, American Heart
Association congress 2003, Orlando, USA.
8
Best clinical abstract award, Austrian Society of Cardioloy congress 2004
for the work “Statins but not ACE-inhibitors reduce aortic stenosis
progression”, Salzburg, Austria.
9
Young Investigator Award 2004 - Euroecho 8 – Congress for the work “Statins
But Not ACE-Inhibitors Slow Aortic Stenosis Progression”. December 2004,
Athens, Greece.
10
Austrian Cardiology award (first prize), Austrian Society of Cardioloy 2005
for the work “Statins But Not ACE-Inhibitors Slow Aortic Stenosis
Progression”. May 2005, Salzburg, Austria.
11
Award Researcher of the Month – Medical University of Vienna
for the work “Statins But Not ACE-Inhibitors Slow Aortic Stenosis
Progression”. June 2005, Vienna, Austria.
12
Price for the best postdoctoral lecture qualification 2006
Medical University of Vienna. May 2006, Vienna, Austria.
13
Austrian Cardiology award (first prize), Austrian Society of Cardioloy 2006
for the work „Outcome of watchful waiting in severe but asymptomatic mitral
regurgitation“. June 2006, Salzburg, Austria.
Publications
1
Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G,
Baumgartner H.
„Predictors of outcome in severe, asymptomatic aortic stenosis“
NEW ENGL J MED 2000;343(9):611-7.
Editorial: Otto CM.
„Aortic stenosis – listen to the patient, look at the valve“
NEW ENGL J MED 2000;343(9):652-4.
2
Binder T, Rosenhek R, Frank H, Gwechenberger M, Maurer G, Baumgartner H.
„Congenital malformations of the right atrium and the coronary sinus: an
analysis based on 103 cases reported in the literature and two additional
cases“
CHEST 2000;117(6):1740-8.
3
Binder TM, Rosenhek R, Porenta G, Maurer G, Baumgartner H.
„Improved assessment of mitral valve stenosis by volumetric real-time
three-dimensional echocardiography“
J AM COLL CARDIOL 2000;36(4):1355-61.
4
Rosenhek R, Maurer G, Baumgartner H.
„Should early elective surgery be performed in patients with severe but
asymptomatic aortic stenosis?“
EUR HEART J 2002 Sep;23(18):1417-21.
5
Rosenhek R, Binder T.
„Monitoring of invasive procedures – the role of echocardiography in
cathlab and operating room“
J CLIN BASIC CARDIOL 2002; 5: 139-43.
6
Rosenhek R, Binder T, Maurer G.
„Intraoperative transesophageal echocardiography in valve replacement
surgery“
ECHOCARDIOGRAPHY 2002 Nov;19(8):701-7.
7
Rosenhek R, Korschineck I, Gharehbaghi-Schnell E, Jakowitsch J, Bonderman
D, Huber K, Czerny M, Schleef RR, Maurer G, Lang IM.
„Fibrinolytic balance of the arterial wall: pulmonary artery displays
increased fibrinolytic potential compared with aorta“
LAB INVEST 2003;83(6):871-6.
8
Rosenhek R, Binder T, Maurer G, Baumgartner H.
“Normal Values for Doppler Echocardiographic Assessment of Heart Valve
Prostheses”
J AM SOC ECHOCARDIOGR 2003;16(11):1116-27.
9
Rosenhek R, Klaar U, Schemper M, Scholten Ch, Heger M, Gabriel H, Binder
Th, Maurer G, Baumgartner H.
„Mild and moderate aortic stenosis – natural history and risk stratification
by echocardiography“
EUR HEART J 2004;25(3):199-205.
Editorial: Otto CM.
Aortic stenosis: „even mild disease is significant“
EUR HEART J 2004;25(3):185-187.
10
Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H,
Binder T, Pacher R, Maurer G, Baumgartner H.
„Natriuretic peptides predict symptom-free survival and postoperative
outcome in severe aortic stenosis“
CIRCULATION 2004;109(19):2302-8.
11
Mascherbauer J, Schima H, Rosenhek R, Czerny M, Maurer G, Baumgartner H.
„Value and limitations of aortic valve resistance with particular
consideration of low flow-low gradient aortic stenosis: an in vitro study“
EUR HEART J 2004;25(9):787-93.
12
Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M,
Binder T, Maurer G, Baumgartner H.
„Statins but not angiotensin-converting enzyme inhibitors delay
progression of aortic stenosis“
CIRCULATION 2004;110(10):1291-5.
Editorial: Rajamannan NM, Otto CM.
Targeted therapy to prevent progression of calcific aortic stenosis.
CIRCULATION 2004;110(10):1180-2.
13
Scholten C, Rosenhek R, Binder T, Zhetgruber M, Maurer G, Baumgartner H.
“Hand-held miniaturized cardiac ultrasound instruments for rapid and
effective bedside diagnosis and patient screening”
J EVAL CLIN PRACT 2005;11(1):67-72.
14
Heger M, Willfort A, Neunteufl T, Rosenhek R, Gabriel H, Wollenek G,
Wimmer M, Maurer G, Baumgartner H.
“Vascular Dysfunction after Coarctation Repair is Related to Age at
Surgery”
INT J CARDIOL 2005;99(2):295-9.
15
Mascherbauer J, Rosenhek R, Bittner B, Binder J, Simon P, Maurer G, Schima
H, Baumgartner H.
“Doppler echocardiographic assessment of valvular regurgitation severity
by measurement of the vena contracta: an in vitro validation study”.
J AM SOC ECHOCARDIOGR 2005;18(10):999-1006.
16
Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Gabriel H, Binder T, Pacher
R, Maurer G, Baumgartner H.
“Big endothelin-1 is not a predictor in aortic stenosis, but is related to
arterial blood pressure”
INT J CARDIOL 2006 Nov 10;113(2):174-80.
17
Rosenhek R,
Editorial „Statins for Aortic Stenosis“
N ENGL J MED 2005 Jun;352(23):2441-3.
18
Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, Schemper M,
Maurer G, Baumgartner H.
„Outcome of watchful waiting in severe but asymptomatic mitral
regurgitation“
CIRCULATION 2006;113:2238-44.
19
Rosenhek R, Baumgartner H.
„Aortic sclerosis, aortic stenosis and lipid lowering therapy“
EXPERT REV CARDIOVASC THER. 2008 Mar;6(3):385-90.
20
Takkenberg JJ, Rajamannan NM, Rosenhek R, Kumar AS, Carapetis JR,
Yacoub MH; Society for Heart Valve Disease.
„The need for a global perspective on heart valve disease epidemiology. The
SHVD working group on epidemiology of heart valve disease founding
statement“
J HEART VALVE DIS. 2008 Jan;17(1):135-9.
21
Mascherbauer J, Rosenhek R, Fuchs C, Pernicka E, Klaar U, Scholten C, Heger
M, Wollenek G, Maurer G, Baumgartner H.
„Moderate patient-prosthesis mismatch after valve replacement for severe aortic
stenosis has no impact on short-term and long-term mortality.
Heart. 2008 Dec;94(12):1639-45.
22
Rosenhek R.
„Aortic stenosis“
Rev Prat. 2009 Feb 20;59(2):178-81.
23
Zimpfer D, Aharinejad S, Holfeld J, Thomas A, Dumfarth J, Rosenhek R,
Czerny M, Schaden W, Gmeiner M, Wolner E, Grimm M.
„Direct epicardial shock wave therapy improves ventricular function and induces
angiogenesis in ischemic heart failure. “
J Thorac Cardiovasc Surg. 2009 Apr;137(4):963-70.
Book Contributions
1
Rosenhek R., Baumgartner H.
“Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis”
Chapter 52: In Harrison’s Advances in Cardiology.
Editor: Eugene Braunwald.
McGraw-Hill Publishing, 2003.
2
Rosenhek R, Baumgartner H.
„Normal Echocardiographic Data of Prosthetic Valves“
In Management of Patients after Heart Valve Surgery.
Editors: Eric Butchart, Christa Gohlke-Bärwolf, Manuel Antunes, Roger Hall.
Taylor and Francis Medical Publishing, 2006.
3
Rosenhek R.
„Aortic Stenosis: Echocardiographic evaluation of disease severity, disease
progression, and the role of echocardiography in clinical decision making.“
In The Practice of Clinical Echocardiography. 3rd edition.
Editor: Catherine Otto.
W.B. Saunders, 2007.
4
Rosenhek R, Baumgartner H.
„Aortic Stenosis“
In Valvular Heart Disease. 3rd edition.
Editors: Catherine Otto, Robert Bonow.
W.B. Saunders, 2009 (in press).
Invited Talks at International Scientific Meetings
1
Natural history and progression of mild aortic stenosis
Sesión Clínica General, Hospital General Vall d’Hebron
June 6, 2003, Barcelona, Spain
2
Challenging issues in valvular heart disease: applying the guidelines:
Asymptomatic moderate aortic stenosis
Main session
European Society of Cardiology Congress 2003
August 30 – September 3, 2003, Vienna, Austria
3
New aspects of aortic stenosis: Natural history of the asymptomatic patient
European Society of Cardiology Congress 2003
August 30 – September 3, 2003, Vienna, Austria
4
Interactive case presentation: Difficult sitations in patients with mechanical
valve prosthesis: The patient with high transprosthetic gradient
(Focus Session)
European Society of Cardiology Congress 2003
August 30 – September 3, 2003, Vienna, Austria
5
Asymptomatic aortic stenosis
Joint session European Society of Cardiology / French Society of Cardiology
14th Journées Européennes de la Société Française de Cardiologie
January 21 – January 24, 2004, Paris, France
6
Role of Dobutamine testing in the decision making for surgery in patients
with aortic stenosis
Joint session European Society of Cardiology / Portuguese Society of Cardiology
25th Congress of the Portuguese Society of Cardiology
March 29, 2004, Vilamoura, Portugal
7
New indications for aortic valve surgery based on echocardiographic results
12th Alpe Adria Cardiology Meeting
April 29 – May 1, 2004, Cividale del Friuli, Italy
8
Management of the asymptomatic patient with valve disease: from
guidelines to practice: Aortic stenosis
Main session
European Society of Cardiology Congress 2004
August 28 – September 1, 2004, Munich, Germany
9
The burden of aortic stenosis: When is sudden death a real threat in aortic
stenosis?
European Society of Cardiology Congress 2004
August 28 – September 1, 2004, Munich, Germany
10
Case Presentation: 48 year old male, Systolic murmur
Cardiology 2004 – Vienna & Mayo
September 12 - September 14, 2004, Vienna, Austria
11
Management von Patienten mit Aortenstenose
Fortbildung, Krankenhaus Tulln
September 21, 2004, Tulln, Austria
12
Progression of disease and implications for monitoring: Aortic stenosis – A
preventable disease?
Main session
Euroecho 8
December 1 – December 4, 2004, Athens, Greece
13
Update Aortenstenosen
Fortbilung, Universitätsklinik für Notfallmedizin
April 5, 2005, Vienna, Austria
14
Update Aortenstenose
Fortbilung, 1. Med. SMZ-Ost
April 25, 2005, Vienna, Austria
15
Transcatheter closure of atrial septal defects in patients of advanced age
16th International Meeting of the French Society of Echocardiography
June 8 - June 10, 2005, Paris, France
16
Natural History of Aortic stenosis and echocardiographic predictors of
outcome
16th International Meeting of the French Society of Echocardiography
June 8 - June 10, 2005, Paris, France
17
Stressechokardiographie bei Vitien
2. Leipziger Echokardiographie-Symposium
June 2005, Leipzig, Germany
18
Dobutamine Echocardiography in Valvular Heart Disease
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
19
The Natural History of Aortic Stenosis – is There a Role for Statins
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
20
The Patient With a High Transprosthetic Gradient
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
21
Aortenklappenstenose
Echokardiographie Kongress Köln
November 3 – November 5, 2005, Cologne, Germany
22
From Aortic Sclerosis to Aortic Stenosis – Teaching Course
Echocardiography
Euroecho 9
December 3 – December 5, 2005, Florence, Italy
23
Are Practice Guidelines in Line with Recommendations with Respect to
Valve Disease: Aortic Valve Diseases
16th Journées Européennes de la Société Française de Cardiologie
January 18 – January 21, 2006, Paris, France
24
Patient mit asymptomatischer Aortenstenose
Patient nach Klappenersatz
Modernes Case-Management in der Kardiologie - interaktive Fallpräsentationen
February 25, 2006, Grafenegg, Austria
25
What You Need to Know About Degenerative Mitral Regurgitation –
Timing of Intervention: The Viewpoint From Vienna
Symposium - American College of Cardiology 55th Annual Scientific Session
March 11 – March 14, 2006, Atlanta, United States of America
26
Asymptomatic Aortic Stenosis – Degree of Calcium, Rate of Change in Peak
Velocity and Role of Exercise Hemodynamics
Symposium E3 Essential Echocardiography with Experts – American Society of
Echocardiography
March 11 2006, Atlanta, United States of America
27
Asymptomatic Aortic Stenosis Should be Treated – Pro Debator
Symposium Heart to Heart Series – First Forum
March 29 – March 31, 2006, Sevilla, Spain
28
Timing and Indications for Surgery in Asymptomatic Aortic Stenosis
Edwards Heart to Heart Series – Module 2
April 6, 2006, Paris, France
29
Aortenklappenerkrankungen 2006 – Diagnose und Therapiemöglichkeiten:
Aortenisthmusstenose
State of the Art Symposium
May 6, 2006, Grafenegg, Austria
30
Aortenklappenerkrankungen 2006 – Diagnose und Therapiemöglichkeiten:
Aortenstenose
State of the Art Symposium
May 6, 2006, Grafenegg, Austria
31
Aortenstenose konservative Behandlungskonzepte: Statine, Ezetimibe oder
beide
Essen-Mayo-Symposium
May 19 - May 20, 2006, Essen, Germany
32
Aortic Stenosis Update: From Basics to Prognosis
Hadassah University Hospital
May 30, 2006, Jerusalem, Israel
33
Highlights 2005: Klappenerkrankungen
Österreichische Kardiologische Gesellschaft
June 7 - June 10, 2006, Salzburg, Austria
34
Chairmens Summary: Featured Research Session – Rheumatic Fever /
Heart Disease: Still a Challenge?
European Society of Cardiology Congress/World Congress of Cardiology 2006
September 2 – September 6, 2006, Barcelona, Spain
35
Valvular Heart Disease: Asymptomatic Moderate and Severe Aortic
Stenosis: ESC Guidelines, ACC/AHA Guidelines. Does MSCT play a role?
Cardiology 2006 – Vienna & Mayo
September 14 - September 16, 2006, Vienna, Austria
36
Aortic Stenosis: Pitfalls in Quantitative Assessment, Risk Stratification in
Asymptomatic Severe AS; the Difficult Patient With Impaired LV Function
and Low Gradient
European Association of Echocardiography – Teaching Course: Transthoracic
Echocardiography – Diagnostic Methods and Clinical Cases
September 21 – September 23, 2006, Vienna, Austria
37
Asymptomatic Aortic Stenosis: Risk Stratification with Echocardiography
and BNP
Journées Echo-Doppler Cardio-Vasculaire
September 27 – September 29, 2006, Bordeaux, France
38
Asymptomatic Mitral Regurgitation: Risk Stratification
Journées Echo-Doppler Cardio-Vasculaire
September 27 – September 29, 2006, Bordeaux, France
39
Operationsindikationen bei der Mitralinsuffizienz
Fortbildung Herzchirurgie, Medical University of Vienna
October 18, 2006, Vienna, Austria
40
Diagnostik bei Herzklappenfehlern: Aortenklappenstenose
Echokardiographie Kongress Köln
November 2 – November 4, 2006, Cologne, Germany
41
Neue Richtlinien und Aspekte für die Behandlung von Herzfehlern
Symposium Schloss Wilhelminenberg
December 2, 2006, Vienna, Austria
42
Aortic Stenosis – What and How to Measure?
Euroecho 10
December 6 – December 9, 2006, Prague, Czech Republic
43
When Should we Operate on Asymptomatic Dystrophic Mitral
Regurgitation?
It is Possible to Wait
17th Journées Européennes de la Société Française de Cardiologie
January 17 – January 20, 2007, Paris, France
44
Timing and Indications of Surgery in Degenerative Mitral Regurgitation:
Debate: Watchful Waiting
Master of Valve Repair Programme
March 19, 2007, Harefield, United Kingdom
45
Challenges and Controversies in Valvular Heart Disease: Mitral Valve
Surgery in the Asymptomatic Patient: Can it Be Justified?
Symposium - American College of Cardiology 56th Annual Scientific Session
March 26, 2007, New Orleans, United States of America
46
Risk Stratification and Timing of Surgery in Asymptomatic Aortic Stenosis
The Center of Heart Valve Disease Meeting
Bluhm Cardiovascular Institute - Northwestern University
March 29, 2007, Chicago, United States of America
47
Aortenklappeninsuffizienz: wann operieren?
Frühjahrstagung der Deutschen Gesellschaft für Kardiologie
April 13, 2007, Mannheim, Germany
48
Aortic Regurgitation and the aortic root: Management Issues
5th Vienna Interdisciplinary Symposium on Aortic Repair (VISAR)
April 19, 2007, Vienna, Austria
49
Operationsindikation bei Aortenstenose und Insuffizienz - Update 2007 im
Lichte der neuen amerikanischen und europäischen Guidelines
DACH meeting
May 5, 2007, Vienna, Austria
50
Aortic Sclerosis, Aortic Stenosis and Lipid Lowering Therapy
Cardiology and Vascular Medicie – Update and Perspective
May 8, 2007, Rotterdam, Netherlands
51
Behandlung der Asymptomatischen AS: Kann eine Therapie mit Statinen
oder anderen Medikamenten schon empfohlen werden? Wann kann man
eine Operation rechtfertigen?
Österreichische Kardiologische Gesellschaft
May 31, 2007, Salzburg, Austria
52
Rôle de la quantification des valvulopathies dans la prise en charge des
patients: jusqu’où? Rétrécissement aortique
17th International Meeting of the French Society of Echocardiography
June 6 - June 8, 2007, Paris, France
53
Clinical standards for mitral valve repair: The „watchful waiting“approach
to severe mitral regurgitation
Manchester Mitral Valve Meeting 2007
June 20, 2007, Manchester, United Kingdom
54
Gradientenmessungen an Herzklappenprothesen: Wann ist eine Prothese
zu klein?
6. Leipziger Echokardiographie-Symposium
June 22- June 23 2007, Leipzig, Germany
55
Die konventionelle Quantifizierung des Schweregrades der Mitralstenose Echokardiographische Grundlagen
6. Leipziger Echokardiographie-Symposium
June 22- June 23 2007, Leipzig, Germany
56
The valve patient and pregnancy: When should valve disease be corrected
before pregnancy?
European Society of Cardiology Congress 2007
September 2, 2007, Vienna, Austria
57
Mitral regurgitation - current approach: The asymptomatic patient
European Society of Cardiology Congress 2007
September 3, 2007, Vienna, Austria
58
Managemt of severe mitral regurgitation
Grand rounds, Rudolfstiftung hospital
September 12, 2007, Vienna, Austria
59
Debate: Asymptomatic Severe Mitral Regurgitation. Watchful Waiting vs.
Early Referral
European Association of Cardiothoracic Surgery Meeting
September 18, 2007, Geneva, Switzerland
60
Management of Asymptomatic Aortic Stenosis
Echo-Cardio Symposium Benelux and Nordic Countries
September 28, 2007, Brussels, Belgium
61
Clinical management of organic mitral regurgitation
Third Joint Symposium of the Research Group in Valve Diseases and the
Canada Research Chair in Valvular Heart Diseases
October 10, 2007, Montreal, Canada
62
Clinical management of asymptomatic patients with severe aortic stenosis
Third Joint Symposium of the Research Group in Valve Diseases and the
Canada Research Chair in Valvular Heart Diseases
October 11, 2007, Montreal, Canada
63
Timing and Indications for Surgery in Aortic stenosis and Regurgitation an Update Considering the new ESC and ACC/AHA Guidelines
Ukrainian Association of Internal Medicine Training Course
October 18-20, 2007, Kiev, Ukraine
64
Management of Asymptomatic Mitral Regurgitation
Ukrainian Association of Internal Medicine Training Course
October 18-20, 2007, Kiev, Ukraine
65
Asymptomatic Mitral Regurgitation
Echokardiographie Kongress Köln
November 8, 2007, Cologne, Germany
66
Prognostic value of echocardiography in valvular heart disease: aortic
stenosis
Euroecho 11
December 5 – December 8, 2007, Lisbon, Portugal
67
What approach concerning moderate calcific aortic stenosis
18th Journées Européennes de la Société Française de Cardiologie
January 16 – January 19, 2008, Paris, France
68
Valve diseases: the crucial role of echocardiographic quantification for
surgical indications - in aortic stenosis
18th Journées Européennes de la Société Française de Cardiologie
January 16 – January 19, 2008, Paris, France
69
What should be used to supplement the ultrasonographic assessment of
valve disease? Biomarkers?
18th Journées Européennes de la Société Française de Cardiologie
January 16 – January 19, 2008, Paris, France
70
New Insights in the Pathophysiology of Aortic Stenosis
Edwards Heart to Heart Series – Module 9
February 7, 2008, Paris, France
71
Debate: Severe Mitral Regurgitation in Asymptomatic Patients. Early
Referral or Watchful Waiting? Watchful Waiting?
Master of Valve Repair Programme
February 18, 2008, Leiden, The Netherlands
72
Asymptomatic Valvular Heart Disease: There’s No Rush: Follow Carefully
ACC.ClinCard 2008 - American College of Cardiology 57th Annual Scientific
Session
March 30, 2008, Chicago, United States of America
73
Emerging Concepts in the Pathogenesis of Aortic Valve Disease:
Biomarkers and Progression
Symposium - American College of Cardiology 57th Annual Scientific Session
March 31, 2008, Chicago, United States of America
74
The Natural History of Aortic Stenosis
Edwards Heart to Heart Series
April 11, 2008, Rome, Italy
75
Aortic Sclerosis, Aortic Stenosis and Lipid Lowering Therapy
Sesión Clínica General, Hospital General Vall d’Hebron
June 6, 2008, Barcelona, Spain
76
Noncardiac Surgery in Asymptomatic Aortic Stenosis
European Society of Cardiology Congress 2008
September 1, 2008, Munich, Germany
77
Timing of Surgery in Asymptomatic Aortic Regurgitation
Edwards Heart to Heart Series – Module 14
October 2, 2008, Paris, France
78
Aortenstenose: von der Pathogenese zur Risikostratifizierung
Experten Meeting „State of the Art – Aortenstenose“
October 3, 2008, Vienna, Austria
79
Percutaneous Aortic Valve Implantation
British Society of Echocardiography
October 4, 2008, Leeds, United Kingdom
80
Aortic Regurgitation – Timing of Surgery
International Training Course
October 16-18, 2008, Kiev, Ukraine
81
Aortic Stenosis – From Pathogenesis to Risk Stratification
International Training Course
October 16-18, 2008, Kiev, Ukraine
82
Case Presentation - Aortic Stenosis – Calcification, Jet Velocity and
Progression
International Training Course
October 16-18, 2008, Kiev, Ukraine
83
Management of Asymptomatic Severe Aortic Stenosis: Listen to the Patient
and Look at the Valve
American Heart Association Scientific Sessions 2008
November 9, 2008, New Orleans, United States of America
84
The Dilemma of Timing for Surgery in Mitral Regurgitation: The
„watchful waiting“ approach
Mitrale Meeting 2008
November 20, 2008, Milan, Italy
85
New Frontiers in Mitral Regurgitation: Tools Helping to Predict Outcome
Symposium of the Belgian Working Group of Non-invasive Cardiology 2008
November 22, 2008, Liège, Belgium
86
Aortic root evaluation: The problem of aortic valvular disease due to
ascending aortic disease
Euroecho 12
December 5 – December 8, 2008, Lyon, France
87
Prognostic value of calcium in the aortic valve
Euroecho 12
December 5 – December 8, 2008, Lyon, France
88
Asymptomatic Severe Aortic Stenosis: Calcification, Progression and
Exercise Testing
ESC - ETP Course Heart House
February 19-21, 2009, Sophia Antipolis, France
89
Asymptomatic Severe Mitral Regurgitation: Watchful Waiting or Surgery?
ESC - ETP Course Heart House
February 19-21, 2009, Sophia Antipolis, France
90
Low Gradient Aortic Stenosis and Heart Failure
ESC - ETP Course Heart House
February 19-21, 2009, Sophia Antipolis, France
91
The Patient with a High Transprosthetic Gradient
ESC - ETP Course Heart House
February 19-21, 2009, Sophia Antipolis, France
92
Asymptomatische wirksame Aortenstenose: Natürlicher Verlauf und
Zeitpunkt der Operation beziehungsweise Intervention
Kardiologie Innsbruck
March 6-7, 2009, Innsbruck, Austria
93
New Insights in the Pathophysiology of Aortic Stenosis and Review of Statin
Trials
Edwards Heart to Heart Series
March 12, 2009, Paris, France
94
Early Elective Surgery in Severe Asymptomatic Aortic Stenosis: When I do
it, when I don’t
Edwards Heart to Heart Series
March 12, 2009, Paris, France
95
Mitralklappenvitien: Indikationen zur Klappenoperation
Fortbildung Herzchirurgie, Medical University of Vienna
March 25, 2009, Vienna, Austria
96
Aortic root diseases: Treatment of concomitant aortic valve disease – the
role of TTE
6th Vienna Interdisciplinary Symposium on Aortic Repair (VISAR)
April 22, 2009, Vienna, Austria
97
When to operate on asymptomatic aortic stenosis?
„Indications opératoires en cas de rétrécissement aortique asymptomatique“
18th International Meeting of the French Society of Echocardiography
May 27-29, 2009, Paris, France
98
Decisional Value of echocardiography in the treatment of valvular heart
diseases: Aortic Stenosis
„Valeur décisionelle de l’échocardiographie dans la prise en charge
thérapeutique des valvulopathies: rétrécissement aortique“
18th International Meeting of the French Society of Echocardiography
May 27-29, 2009, Paris, France
99
Highlight Session: Valvular Heart Disease
European Society of Cardiology Congress 2009
September 2, 2009, Barcelona, Spain
100
Stratifying risk in the Asymptomatic Patient with Severe Valvular Heart
Disease: Aortic Stenosis
European Society of Cardiology Congress 2009
September 1, 2009, Barcelona, Spain
101
Difficult Decisions in Aortic Stenosis: Risk Stratification and Timing of
Surgery
European Society of Cardiology Congress 2009
September 1, 2009, Barcelona, Spain
102
Bicuspid Aortic Valve Disease
September 18-19, 2009, St Malo, France
103
Decision Making and Optimal Timing of Mitral Valve Treatment in Elderly
Patients
European Association of Cardiothoracic Surgery Meeting
October 17-21, 2009, Vienna, Austria
103
Management of the Patient with Asymptomatic Mitral Valve Disease:
Wachful Waiting vs Surgery Before it is Too Late
American Heart Association Scientific Sessions 2009
November 15, 2009, Orlando, United States of America
Invited Chairs at International Scientific Meetings
1
Chairman: Contemporary management of aortic valve disease
(Co-Chairman Dan Gilon, Jerusalem IL)
European Society of Cardiology Congress 2003
August 30 – September 3, 2003, Vienna, Austria
2
Chairman: Moderated Poster Session
16th International Meeting of the French Society of Echocardiography
June 8 - June 10, 2005, Paris, France
3
Chairman: Stress-echokardiographie bei Vitien
(Co-Chairman Wolfgang Fehske, Köln DE)
2. Leipziger Echokardiographie-Symposium
Juni 2005, Leipzig, Germany
4
Chairman: Aortic Regurgitation and the Aortic Root
(Co-Chairman Eric Butchart, Cardiff, GB)
European Society of Cardiology Congress 2005
September 3 – September 7, 2005, Stockholm, Sweden
5
Chairman: Predicting Outcome in Valve Disease
(Co-Chairman Catherine Otto, Seattle US)
European Society of Cardiology Congress 2005
September 3 – September 7, 2005, Stockholm, Sweden
6
Chairman: Pharmacotherapy of Coronary Artery Disease – Controversial
Issues and Feedback
(Co-Chairman G Dzak, Dnipetrovsk UA and Viktor Tashchuck, Chernivci UA)
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
7
Chairman: Arterial Hypertension – some Pharmacotherapeutic Aspects
(Co-Chairman Boris Mankovskyi, Kiev UA and Maryna Dolzhenko, Kiev UA)
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
8
Chairman: Special Cardiology in Clinical Situations – Optimization of
Treatment Approaches
(Co-Chairman Yu Sirenko, Kiev UA and Marina Sharayeva, Kiev UA)
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 7 – October 8, 2005, Kiev, Ukraine
9
Chairman: Are Practice Guidelines in Line with Recommendations with
Respect to Valve Disease?
(Co-Chairman Christophe Tribouilloy, Amiens, FR)
16th Journées Européennes de la Société Française de Cardiologie
January 18 – January 21, 2006, Paris, France
10
Chairman: Aortenklappenerkrankungen 2006 – Diagnose und
Therapiemöglichkeiten
State of the Art Symposium
(Co-Chairman Herbert Frank, Tulln, AT)
May 6, 2006, Grafenegg, Austria
11
Chairman: Towards less Invasive Treatment of Valve Disease
(Co-Chairman Manuel Antunes, Coimbra PT)
European Society of Cardiology Congress 2006
September 2 – September 6, 2006, Barcelona, Spain
12
Chairman: Featured Research Session – Rheumatic Fever / Heart Disease:
Still a Challenge?
(Co-Chairman A Achutti, Porto Alegre BR)
European Society of Cardiology Congress/World Congress of Cardiology 2006
September 2 – September 6, 2006, Barcelona, Spain
13
Chairman: Moderated Poster Session: Valvular Heart Disease and
Pulmonary Hypertension
Österreichische Kardiologische Gesellschaft
May 31, 2007, Salzburg, Austria
14
Rôle de la quantification des valvulopathies dans la prise en charge des
patients: jusqu’où?
(Co-Chairman: Eric Abergel, FR)
17th International Meeting of the French Society of Echocardiography
June 6 - June 8, 2007, Paris, France
15
Chairman: Abstract Session: Aortic Stenosis – New directions
(Co-Chairman: Janina Stepinska, Warsaw PL)
European Society of Cardiology Congress 2007
September 2, 2007, Vienna, Austria
16
Chairman: Pharmacotherapy of Coronary Artery Disease – Controversial
Issues and Feedback
(Co-Chairman G Dzak, Dnipetrovsk UA and Viktor Tashchuck, Chernivci UA)
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 19 – October 20, 2007, Kiev, Ukraine
17
Chairman: Arterial Hypertension – some Pharmacotherapeutic Aspects
(Co-Chairman Boris Mankovskyi, Kiev UA and Maryna Dolzhenko, Kiev UA)
ETP Course on Cardiovascular Therapy
organized by the European Society of Cardiology
October 19 – October 20, 2007, Kiev, Ukraine
18
Chairman: Kongenitale Vitien im Erwachsenenalter
(Co-Chairman Konrad Brockmeier, Cologne DE)
Echokardiographie Kongress Köln
November 8, 2007, Cologne, Germany
19
Chairman: New applications of imaging techniques in aortic stenosis
(Co-Chairman: Gerald Maurer, Vienna AT)
Euroecho 11
December 5 – December 8, 2007, Lisbon, Portugal
20
Panelist: Asymptomatic Valvular Heart Disease
ACC.ClinCard 2008 - American College of Cardiology 57th Annual Scientific
Session
March 30, 2008, Chicago, United States of America
21
Chairman: Bicuspid Aortic Valve Disease: An Old Disease With a New
Name?
(Co-Chairman: Janina Stepinska, Warsaw PL)
European Society of Cardiology Congress 2008
August 8, 2008, Munich, Germany
22
Chairman: Surgical Mortality in Low Gradient Aortic Stenosis
Symposium of the Belgian Working Group of Non-invasive Cardiology 2008
November 22, 2008, Liège, Belgium